Total employees
60
Harpoon Therapeutics is a clinical-stage immuno-oncology company focused on developing T cell engagers using proprietary platforms, including TriTAC® for solid tumors and hematologic malignancies. As of March 11, 2024, it is a subsidiary of Merck & Co., Inc.
Info powered by Clay
https://www.harpoontx.com/
View on LinkedIn
South San Francisco, California
Explore Clay
Explore more companies
Oops! Something went wrong while submitting the form.
Clay Templates
Find more company data using our pre-built Clay templates.
Find Key Decision Makers
Find Number of Open Roles
Find International Employees
See all templates
Learn Clay
Go to our University library to get started and learn with our tutorials.
See all our tutorials
Historical Data
employee per department